Burkitt Lymphoma
📧 Sign up to get email alerts when something new happens for Burkitt Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-12-02Clinical Trial Update: T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies [Phase 1, Phase 2]
A trial investigating T-regulatory cell and CD3-depleted double umbilical cord blood transplantation for hematologic malignancies has been w…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas [Phase 1]
Phase I study of alisertib combined with R-EPOCH for myc-positive aggressive B-cell lymphomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Safety Study of SGN-CD19A for B-Cell Lymphoma [Phase 1]
Phase 1 safety study of SGN-CD19A in various B-cell lymphomas has completed; the update summarizes safety results across multiple indication…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Safety Study of SGN-CD19A for Leukemia and Lymphoma [Phase 1]
Phase 1 safety study of SGN-CD19A in patients with Burkitt lymphoma and precursor B-cell lymphoblastic leukemia/lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen with alemtuzumab, fludarabine phosphate, and total-body irradiation followed by cyclosporine…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a combination of vorinostat, rituximab, ifosfamide, carboplatin, and etoposide in adults with relapsed/refracto…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [NA]
Clinical trial update reports results of a conditioning regimen using fludarabine and total-body irradiation followed by donor stem cell tra…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
Phase 2 trial evaluating haploidentical donor bone marrow transplantation in patients with high-risk hematologic cancers; results completed …
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and tolerability of HSC835 in patients with various hematologic malignancies completed with results posted …
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [NA]
A terminated clinical trial evaluated mobilizing donor peripheral blood stem cells with plerixafor and filgrastim before donor transplant in…
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults
This clinical trial update presents a retrospective analysis of rituximab-containing immunochemotherapy for adults with Burkitt lymphoma or …
-
CLINICAL_TRIALS research · 2016-12-21Clinical Trial Update: To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma [Phase 4]
This clinical trial update notes a Phase 4 study comparing the duration of prophylactic Tenofovir use in patients with Non-Hodgkin lymphoma,…
-
CLINICAL_TRIALS withdrawal · 2016-08-11Clinical Trial Update: Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 study of Rituximab, Romidepsin, and Lenalidomide for recurrent or refractory B-cell non-Hodgkin lymphoma has been withdraw…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of lenalidomide plus rituximab as maintenance therapy for adult B-cell non-Hodgkin lymphoma is noted as terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603) [Phase 2]
Phase 2 clinical trial update on bone marrow transplantation from partially matched donors with nonmyeloablative conditioning for various bl…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604) [Phase 2]
Phase 2 clinical trial evaluating safety and effectiveness of an umbilical cord blood stem cell transplant for various hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma [Phase 2]
A Phase 2 trial evaluating infusion of blood cells (lymphocytes) to stimulate the immune system for fighting leukemia/lymphoma was terminate…
-
CLINICAL_TRIALS research · 2015-05-07Clinical Trial Update: Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
A completed clinical trial update examining genetic factors linked to non-Hodgkin lymphoma in children, focusing on Burkitt lymphoma and lym…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [Phase 1]
A Phase 1 pilot study evaluated co-infusing ex vivo expanded cord blood cells with an unmanipulated cord blood unit in patients undergoing c…
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors [Phase 1]
Phase 1 trial evaluating RO4929097 in combination with capecitabine in patients with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Rituximab Combined With Chemotherapy in Burkitt's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in combination with chemotherapy for Burkitt lymphoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia [Phase 2]
Phase 2 trial evaluating rituximab with chemotherapy and filgrastim in Burkitt's lymphoma or Burkitt's leukemia; study completed with result…